Hospitalisation and mortality risk of SARS-COV-2 variant omicron sub-lineage BA.2 compared to BA.1 in England (2022)
Attributed to:
Evidence Synthesis to inform health related decision making
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41467-022-33740-9
PubMed Identifier: 36229438
Publication URI: http://europepmc.org/abstract/MED/36229438
Type: Journal Article/Review
Parent Publication: Nature Communications
Issue: 1
ISSN: 2041-1723